| | Number | True loss | % | OR1 | 95% CI | value | Adjusted OR1 | 95% CI | value |
| Sex | | | | | | | | | | Male | 1206 | 584 | 48.4 | 1.00 | | | 1.00 | | | Female | 442 | 209 | 47.3 | 0.89 | (0.69, 1.15) | 0.359 | 0.80 | (0.61, 1.05) | 0.104 |
| Current age (years) | | | | | | | | | | ≤35 | 568 | 278 | 48.9 | 1.00 | | | 1.00 | | 0.0972 | 36~45 | 717 | 340 | 47.4 | 1.33 | (1.03, 1.71) | 0.031 | 1.31 | (1.00, 1.72) | 0.050 | 46+ | 363 | 175 | 48.2 | 1.27 | (0.94, 1.72) | 0.118 | 1.28 | (0.93, 1.77) | 0.128 |
| Reported exposure | | | | | | | | | | Heterosexual contact | 985 | 443 | 45.0 | 1.00 | | | 1.00 | | | Homosexual contact | 344 | 199 | 57.8 | 1.12 | (0.78, 1.60) | 0.532 | 1.24 | (0.85,1.81) | 0.262 | Injecting drug use | 125 | 55 | 44.0 | 1.01 | (0.59, 1.73) | 0.969 | 1.32 | (0.72, 2.41) | 0.364 | Other/unknown | 194 | 96 | 49.5 | 1.07 | (0.69, 1.64) | 0.773 | 1.22 | (0.78, 1.93) | 0.382 |
| Current CD4 count (cells/μl.) | | | | | | | | | | ≤100 | 58 | 36 | 62.1 | 1.00 | | | 1.00 | | | 101–200 | 129 | 66 | 51.2 | 0.76 | (0.36, 1.60) | 0.471 | 0.99 | (0.47, 2.13) | 0.989 | 201+ | 1068 | 465 | 43.5 | 0.62 | (0.33, 1.18) | 0.144 | 0.82 | (0.42, 1.59) | 0.551 | Missing | 393 | 226 | 57.5 | 1.50 | (0.77, 2.93) | 0.238 | 1.18 | (0.58, 2.42) | 0.649 |
| Current HIV RNA (copies/mL) | | | | | | | | | | ≤500 | 598 | 230 | 38.5 | 1.00 | | | 1.00 | | 0.0112 | 501+ | 153 | 78 | 51.0 | 1.02 | (0.68, 1.52) | 0.924 | 0.94 | (0.62, 1.42) | 0.767 | Missing | 897 | 485 | 54.1 | 2.13 | (1.63, 2.80) | <0.001 | 1.54 | (1.13, 2.09) | 0.006 |
| CDC disease stage | | | | | | | | | | Stage A | 828 | 413 | 49.9 | 1.00 | | | 1.00 | | | Stage B | 121 | 54 | 44.6 | 0.77 | (0.48, 1.22) | 0.258 | 0.70 | (0.43, 1.14) | 0.154 | Stage C | 699 | 326 | 46.6 | 1.00 | (0.78, 1.27) | 0.975 | 1.05 | (0.81, 1.36) | 0.702 |
| Tuberculosis diagnosis | | | | | | | | | | Yes | 361 | 186 | 51.5 | 1.00 | | | 1.00 | | | No | 1287 | 607 | 47.2 | 0.87 | (0.66, 1.16) | 0.342 | 0.85 | (0.63, 1.15) | 0.297 |
| Time since HIV infection (years) | | | | | | | | | | ≤5 | 771 | 400 | 51.9 | 1.00 | | | 1.00 | | | 6+ | 858 | 389 | 45.3 | 1.25 | (0.98, 1.60) | 0.076 | 1.03 | (0.79, 1.34) | 0.835 | Missing | 19 | 4 | 21.1 | 0.37 | (0.12, 1.17) | 0.091 | 0.43 | (0.13, 1.43) | 0.170 |
| Hepatitis B infection | | | | | | | | | | Yes | 112 | 47 | 42.0 | 1.00 | | | 1.00 | | | No | 883 | 431 | 48.8 | 1.30 | (0.84, 2.03) | 0.243 | 1.35 | (0.84, 2.16) | 0.222 | N/A | 653 | 315 | 48.2 | 1.31 | (0.82, 2.09) | 0.253 | 1.03 | (0.60,1.76) | 0.908 | Hepatitis C infection | | | | | | | | | | Yes | 149 | 66 | 44.3 | 1.00 | | | 1.00 | | 0.0042 | No | 796 | 376 | 47.2 | 1.57 | (1.01, 2.45) | 0.046 | 1.66 | (1.04, 2.66) | 0.034 | N/A | 703 | 351 | 49.9 | 1.96 | (1.26, 3.05) | 0.003 | 2.16 | (1.35, 3.46) | 0.001 |
| Current anemia (male < 13 g/dL, female < 11 g/dL) | | | | | | | | | Yes | 141 | 87 | 61.7 | 1.00 | | | 1.00 | | <0.0012 | No | 1065 | 456 | 42.8 | 0.53 | (0.35, 0.81) | 0.003 | 0.50 | (0.32, 0.76) | 0.001 | N/A | 442 | 250 | 56.6 | 1.15 | (0.73, 1.81) | 0.549 | 0.78 | (0.49, 1.26) | 0.310 |
| Current ART** | | | | | | | | | | 3 + (NRTI + NNRTI) | 911 | 404 | 44.3 | 1.00 | | | 1.00 | | | 3 + (NRTI + PI) | 356 | 167 | 46.9 | 0.76 | (0.57, 1.02) | 0.072 | 0.74 | (0.54,1.01) | 0.057 | No/mono/double ARV | 352 | 209 | 59.4 | 0.93 | (0.69, 1.26) | 0.644 | 0.78 | (0.57, 1.08) | 0.137 | 3 + (other combination) | 29 | 13 | 44.8 | 0.89 | (0.40, 1.98) | 0.770 | 0.85 | (0.38, 1.94) | 0.707 | Previous episode of temporary LTFU | | | | | | | | | | None | 1298 | 589 | 45.4 | 1.00 | | | 1.00 | | <0.0012 | Once | 296 | 158 | 53.4 | 2.79 | (2.05, 3.80) | <0.001 | 2.71 | (1.97, 3.72) | <0.001 | Twice | 54 | 46 | 85.2 | 31.76 | (13.91, 72.52) | <0.001 | 27.75 | (12.03, 64.01) | <0.001 |
|
|